Sofia D. Merajver, MD, PhD
Sofia D. Merajver, MD, PhD
Professor of Internal Medicine and Epidemiology, University of Michigan
Verified email at - Homepage
Cited by
Cited by
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds
SV Tavtigian, J Simard, J Rommens, F Couch, D Shattuck-Eidens, ...
Nature genetics 12 (3), 333-337, 1996
Genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology
MB Daly, T Pal, MP Berry, SS Buys, P Dickson, SM Domchek, ...
Journal of the National Comprehensive Cancer Network 19 (1), 77-102, 2021
BRCA1 regulates human mammary stem/progenitor cell fate
S Liu, C Ginestier, E Charafe-Jauffret, H Foco, CG Kleer, SD Merajver, ...
Proceedings of the National Academy of Sciences 105 (5), 1680-1685, 2008
International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment
S Dawood, SD Merajver, P Viens, PB Vermeulen, SM Swain, TA Buchholz, ...
Annals of oncology 22 (3), 515-523, 2011
Somatic mutations in the BRCA1 gene in sporadic ovarian tumours
SD Merajver, TM Pham, RF Caduff, M Chen, EL Poy, KA Cooney, ...
Nature genetics 9 (4), 439-443, 1995
NCCN guidelines insights: genetic/familial high-risk assessment: breast and ovarian, version 2.2017
MB Daly, R Pilarski, M Berry, SS Buys, M Farmer, S Friedman, JE Garber, ...
Journal of the National Comprehensive Cancer Network 15 (1), 9-20, 2017
Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis
Q Pan, CG Kleer, KL Van Golen, J Irani, KM Bottema, C Bias, ...
Cancer research 62 (17), 4854-4859, 2002
Assessment and counseling for women with a family history of breast cancer: a guide for clinicians
KF Hoskins, JE Stopfer, KA Calzone, SD Merajver, TR Rebbeck, ...
Jama 273 (7), 577-585, 1995
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
SA Narod, MP Dubé, J Klijn, J Lubinski, HT Lynch, P Ghadirian, ...
Journal of the National Cancer Institute 94 (23), 1773-1779, 2002
RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype
KL van Golen, ZF Wu, XT Qiao, LW Bao, SD Merajver
Cancer research 60 (20), 5832-5838, 2000
BRCA2 germline mutations in male breast cancer cases and breast cancer families
FJ Couch, LM Farid, ML DeShano, SV Tavtigian, K Calzone, L Campeau, ...
Nature genetics 13 (1), 123-125, 1996
Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study
GJ Brewer, RD Dick, DK Grover, V LeClaire, M Tseng, M Wicha, K Pienta, ...
Clinical Cancer Research 6 (1), 1-10, 2000
Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer
LJ Pierce, AM Levin, TR Rebbeck, MA Ben-David, E Friedman, LJ Solin, ...
J Clin Oncol 24 (16), 2437-2443, 2006
NCCN guidelines insights: genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020: featured updates to the NCCN guidelines
MB Daly, R Pilarski, MB Yurgelun, MP Berry, SS Buys, P Dickson, ...
Journal of the National Comprehensive Cancer Network 18 (4), 380-391, 2020
Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor–negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23
B Fisher, S Anderson, E Tan-Chiu, N Wolmark, DL Wickerham, ER Fisher, ...
Journal of clinical oncology 19 (4), 931-942, 2001
A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast …
KL van Golen, S Davies, Z Fen Wu, YF Wang, CD Bucana, H Root, ...
Clinical Cancer Research 5 (9), 2511-2519, 1999
BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants
F Elstrodt, A Hollestelle, JHA Nagel, M Gorin, M Wasielewski, ...
Cancer research 66 (1), 41-45, 2006
Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability
CG Kleer, KL van Golen, Y Zhang, ZF Wu, MA Rubin, SD Merajver
The American journal of pathology 160 (2), 579-584, 2002
Targeting breast cancer stem cell state equilibrium through modulation of redox signaling
M Luo, L Shang, MD Brooks, E Jiagge, Y Zhu, JM Buschhaus, S Conley, ...
Cell metabolism 28 (1), 69-86. e6, 2018
Molecular biology of breast cancer metastasis Inflammatory breast cancer: clinical syndrome and molecular determinants
CG Kleer, KL van Golen, SD Merajver
Breast Cancer Research 2, 1-7, 2000
The system can't perform the operation now. Try again later.
Articles 1–20